MicroRNA‐495‐3p diminishes doxorubicin‐induced cardiotoxicity through activating AKT |
| |
Authors: | Jun Meng Can Xu |
| |
Institution: | 1. The First Affiliated Hospital, Functional Department, Hengyang Medical School, University of South China, Hengyang Hunan, China ; 2. The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang Hunan, China |
| |
Abstract: | Doxorubicin (Dox) is a broad‐spectrum antitumour agent; however, its clinical application is impeded due to the cumulative cardiotoxicity. The present study aims to investigate the role and underlying mechanisms of microRNA‐495‐3p (miR‐495‐3p) in Dox‐induced cardiotoxicity. Herein, we found that cardiac miR‐495‐3p expression was significantly decreased in Dox‐treated hearts, and that the miR‐495‐3p agomir could prevent oxidative stress, cell apoptosis, cardiac mass loss, fibrosis and cardiac dysfunction upon Dox stimulation. In contrast, the miR‐495‐3p antagomir dramatically aggravated Dox‐induced cardiotoxicity in mice. Besides, we found that the miR‐495‐3p agomir attenuated, while the miR‐495‐3p antagomir exacerbated Dox‐induced oxidative stress and cellular injury in vitro. Mechanistically, we demonstrated that miR‐495‐3p directly bound to the 3′‐untranslational region of phosphate and tension homology deleted on chromosome ten (PTEN), downregulated PTEN expression and subsequently activated protein kinase B (PKB/AKT) pathway, and that PTEN overexpression or AKT inhibition completely abolished the cardioprotective effects of the miR‐495‐3p agomir. Our study for the first time identify miR‐495‐3p as an endogenous protectant against Dox‐induced cardiotoxicity through activating AKT pathway in vivo and in vitro. |
| |
Keywords: | AKT doxorubicin‐ induced cardiotoxicity miR‐ 495‐ 3p oxidative stress |
|
|